89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Society of Nuclear Medicine
2016
|
| _version_ | 1797079450946371584 |
|---|---|
| author | Knight, J Mosley, M Bravo, L Fokas, E Cornelissen, B |
| author_facet | Knight, J Mosley, M Bravo, L Fokas, E Cornelissen, B |
| author_sort | Knight, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:46:02Z |
| format | Conference item |
| id | oxford-uuid:84b0b253-661b-48b6-926b-3910c8d715fc |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:46:02Z |
| publishDate | 2016 |
| publisher | Society of Nuclear Medicine |
| record_format | dspace |
| spelling | oxford-uuid:84b0b253-661b-48b6-926b-3910c8d715fc2022-03-26T21:52:44Z89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinomaConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:84b0b253-661b-48b6-926b-3910c8d715fcSymplectic Elements at OxfordSociety of Nuclear Medicine2016Knight, JMosley, MBravo, LFokas, ECornelissen, B |
| spellingShingle | Knight, J Mosley, M Bravo, L Fokas, E Cornelissen, B 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title | 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title_full | 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title_fullStr | 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title_full_unstemmed | 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title_short | 89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| title_sort | 89zr anti γh2ax tat allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma |
| work_keys_str_mv | AT knightj 89zrantigh2axtatallowsearlymonitoringofresponsetogemcitabineandcapecitabinetherapyinpancreaticductaladenocarcinoma AT mosleym 89zrantigh2axtatallowsearlymonitoringofresponsetogemcitabineandcapecitabinetherapyinpancreaticductaladenocarcinoma AT bravol 89zrantigh2axtatallowsearlymonitoringofresponsetogemcitabineandcapecitabinetherapyinpancreaticductaladenocarcinoma AT fokase 89zrantigh2axtatallowsearlymonitoringofresponsetogemcitabineandcapecitabinetherapyinpancreaticductaladenocarcinoma AT cornelissenb 89zrantigh2axtatallowsearlymonitoringofresponsetogemcitabineandcapecitabinetherapyinpancreaticductaladenocarcinoma |